Tandem Diabetes Care (TNDM) Current Leases (2019 - 2026)

Tandem Diabetes Care has reported Current Leases for 8 years, with the latest figure at $20.1 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases fell 2.92% year-over-year to $20.1 million; the trailing twelve-month figure through Mar 2026 stood at $20.1 million (down 2.92% YoY), and the FY2025 full-year result was $19.5 million, up 6.94% from the prior year.
• Current Leases for Q1 2026 stood at $20.1 million, up from $19.5 million in the prior quarter.
• The five-year high for Current Leases was $21.3 million in Q3 2025, with the low at $8.1 million in Q1 2022.
• Historically, Current Leases has averaged $16.7 million across 5 years, with a median of $17.8 million in 2023.
• Annual changes were most pronounced in 2022 — Current Leases fell 14.46% — and 2023, when it jumped 96.15%.
• Tandem Diabetes Care's Current Leases stood at $13.1 million in 2022, then surged by 30.02% to $17.1 million in 2023, then climbed by 6.73% to $18.2 million in 2024, then rose by 6.94% to $19.5 million in 2025, then climbed by 3.27% to $20.1 million in 2026.
• The last three Current Leases figures came in at $20.1 million (Q1 2026), $19.5 million (Q4 2025), and $21.3 million (Q3 2025), per Business Quant data.